Sethuraman Natarajan - Insider Non-Derivative Transactions at Entrada Therapeutics, Inc. (TRDA) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Sep 9, 2024, Sethuraman Natarajan's relationship to Entrada Therapeutics, Inc. (TRDA) is Officer (Chief Scientific Officer), and currently has 183,816 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other TRDA insiders.

Data Source: SEC.
Sethuraman Natarajan - Insider Non-Derivative Transactions of TRDA Common Stock
Sethuraman Natarajan - Insider Non-Derivative Transactions at TRDA
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Sep 10, 2024 Sell -- (Common Stock) 2642 15.09 183816
Sep 7, 2024 Sell -- (Common Stock) 600 15.24 186458
Sep 6, 2024 F -- (Common Stock) 167 15.13 187058
Sep 5, 2024 F -- (Common Stock) 955 15.42 187225
Sep 4, 2024 F -- (Common Stock) 14 17.7 188180
Sep 4, 2024 F -- (Common Stock) 151 16.93 188194
Sep 4, 2024 F -- (Common Stock) 469 15.76 188345
Jul 16, 2024 Sell -- (Common Stock) 638 18 188814
Jul 13, 2024 Sell -- (Common Stock) 600 18 189452
May 21, 2024 Sell -- (Common Stock) 9675 15.19 190052
May 18, 2024 Sell -- (Common Stock) 8305 15.14 199727
May 17, 2024 Sell -- (Common Stock) 1000 15 208032
Mar 6, 2024 F -- (Common Stock) 1505 12.28 209032
Mar 5, 2024 F -- (Common Stock) 414 13.37 210537
Mar 5, 2024 F -- (Common Stock) 347 12.42 210951
Mar 2, 2024 Acquisition -- (Common Stock) 44100 0 211298
Sep 6, 2023 F -- (Common Stock) 449 14.46 167198
Sep 2, 2023 Acquisition -- (Common Stock) 14200 0 167647
Jul 12, 2023 Sell -- (Common Stock) 14852 18.04 153447
Jul 11, 2023 Sell -- (Common Stock) 3026 18 168299
Apr 18, 2023 Sell -- (Common Stock) 3961 18 171325
Mar 3, 2023 F -- (Common Stock) 1058 11.6 189486
Mar 2, 2023 Acquisition -- (Common Stock) 14200 0 175286
Mar 2, 2023 Acquisition -- (Common Stock) 28400 0 190544